Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    K
    Goat Feed · KEV

    CISA KEV: N-able N-central CVE-2026-86218 (CVSS 4.0 10.0 CRITICAL) - N-central Static Code Injection Vulnerability

    N-central is vulnerable to a pre-auth remote code execution This issue affects N-central: before 2026.3.1.14.

    Back to the daily feed
    KEV
    critical

    BGC Risk Score

    Blue Goat Cyber MedTech rubric v1.0 · methodology

    8.1
    of 10
    high
    CVSS technical
    40% · +4.0

    4.0 base 10.0 · CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

    Patient safety
    35% · +1.8

    Delay of care

    Exploit maturity
    15% · +1.5

    On CISA KEV (in-the-wild)

    MedTech exposure
    10% · +0.8

    8/10 network-reachable signals

    How we got to 8.1

    1. 1
      CVSS technical severity (40%)

      Industry-standard exploitability + impact score. We prefer CVSS 4.0 and fall back to 3.1 per the FDA's Feb 2026 premarket cybersecurity guidance. Missing CVSS scores get a neutral 4.0 so unknown vulns are not over- or under-rated.

      4.0 base 10.0 × 40% = +4.00
    2. 2
      Patient safety impact (35%)

      What happens to a patient if this vuln is exploited on a connected device. Auto-inferred from headline, dek, tags, and device class against a curated MedTech keyword library (pacemaker, infusion pump, EHR, PACS, etc.).

      Delay of care → 5 × 35% = +1.75
    3. 3
      Exploit maturity (15%)

      Is anyone actually using this in attacks? KEV listing > weaponized exploit > public PoC > none. KEV alone forces tier=critical regardless of CVSS.

      On CISA KEV (in-the-wild) → 10 × 15% = +1.50
    4. 4
      MedTech exposure (10%)

      How likely this affects clinical operations: presence in our MedTech feed (+4 baseline), network-reachable signals (+3), known device-class tags (+2), identified MedTech vendor (+1).

      Exposure 8/10 × 10% = +0.80

    Tier cutoffs: Critical ≥ 8.5 · High 7.0–8.4 · Notable 4.0–6.9 · Info < 4.0. Full methodology, weights, and changelog at /goatfeed/risk-rubric.

    CVE: CVE-2026-86218

    CVSS 4.0: 10.0 (CRITICAL) - `CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X`

    Weakness: CWE-96

    Vendor / product: N-able N-central

    KEV added: 2026-09-08 · Federal due date: 2026-09-11

    BGC-RS: 8.1 (high) · CVSS 4.0 base 10.0 · patient-safety: delay-of-care · exploit: kev · MedTech exposure 8/10 · methodology

    Vulnerability

    N-central is vulnerable to a pre-auth remote code execution This issue affects N-central: before 2026.3.1.14.

    Required action

    Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.

    Citations
    #kev#cve#n-able
    Need help acting on this?

    Talk to Blue Goat Cyber

    Penetration testing, SBOM, threat modeling, and 524B submission support for MedTech.